46 results
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
, investigation, arbitration or other action from any governmental authority, including, without limitation, the FDA, the EMA, Health Canada, the U.S. Federal … development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action
8-K
EX-1.1
luoop huio
28 Jun 18
Zafgen Announces Proposed Offering of Common Stock
5:01pm
8-K
EX-99.2
k3e7uooayx2i
8 Dec 20
Regulation FD Disclosure
7:40am
8-K
EX-1.1
f3d4asy8dts44n4ftxkn
9 Nov 18
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-1.1
c85v3rtdtgkwmgte
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
S-1
EX-4.2
ui00nmpx0pez ny4eaod
18 Apr 14
IPO registration
12:00am
DEFA14A
EX-2.1
cey3 cwnvj8eqetio
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
EX-2.1
za6 11xsk4a3yvcs
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
EX-10.3
8yl189irphgkqkn9
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.4
3vfxdfti nfrh1m7ryc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am